Parathyroidectomy for nephrolithiasis in primary hyperparathyroidism: Beneficial but not a panacea
- PMID: 34364687
- DOI: 10.1016/j.surg.2021.03.077
Parathyroidectomy for nephrolithiasis in primary hyperparathyroidism: Beneficial but not a panacea
Abstract
Background: Nephrolithiasis is a classic indication for parathyroidectomy in primary hyperparathyroidism patients; however, the effects of parathyroidectomy on nephrolithiasis recurrence are not well studied. The aim was to determine effect of parathyroidectomy on time to first nephrolithiasis recurrence and recurrence rate per patient-years.
Methods: A retrospective cohort study of patients diagnosed with primary hyperparathyroidism and at least one episode of nephrolithiasis was performed. The patients were divided into observation, presurgery, and postsurgery groups. Endpoints were time to first recurrence of nephrolithiasis and average recurrence rate per patient-years.
Results: The cohort was comprised of 1,252 patients. In addition, 334 (27%) patients underwent parathyroidectomy and 918 (73%) were observed. The surgical and nonsurgical groups differed significantly in age, sex, Charlson, calcium, and primary hyperparathyroidism level. Overall recurrence rate was 31.3%. The 5-, 10-, and 15-year recurrence-free survival rates were 74.4%, 56.3%, 49.5%, respectively (presurgery), 82.4%, 70.9%, 62.8%, respectively (postsurgery; P < .0001), and 86.3%, 77.7%, and 70.6%, respectively (observation). The presurgery group had an increased risk of first recurrence compared with the observation group (hazard ratio 1.89; 95% confidence interval, 1.44-2.47). The average recurrence rates among all surgical patients who recurred were 1 event per 4.3 patient-years presurgery versus 1 event per 6.7 patient-years postsurgery (P = .0001).
Conclusion: Recurrent nephrolithiasis is a significant problem in patients with primary hyperparathyroidism. Parathyroidectomy prolongs the time to first recurrence and decreases the number of re-recurrences over time but does not eliminate recurrences. Observation may also be a reasonable approach in selected patients.
Copyright © 2021 Elsevier Inc. All rights reserved.
Comment in
-
Discussion.Surgery. 2022 Jan;171(1):34. doi: 10.1016/j.surg.2021.03.079. Epub 2021 Aug 4. Surgery. 2022. PMID: 34364686 No abstract available.
Similar articles
-
Stones left unturned: Missed opportunities to diagnose primary hyperparathyroidism in patients with nephrolithiasis.Surgery. 2022 Jan;171(1):23-28. doi: 10.1016/j.surg.2021.03.073. Epub 2021 Jul 28. Surgery. 2022. PMID: 34330541
-
Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines.Surgery. 2021 Jan;169(1):87-93. doi: 10.1016/j.surg.2020.04.066. Epub 2020 Jul 9. Surgery. 2021. PMID: 32654861 Free PMC article.
-
Evaluation for Primary Hyperparathyroidism in Patients Who Present With Nephrolithiasis.J Surg Res. 2021 Jan;257:79-84. doi: 10.1016/j.jss.2020.07.049. Epub 2020 Aug 17. J Surg Res. 2021. PMID: 32818787
-
Mild primary hyperparathyroidism: a literature review.Oncologist. 2014 Sep;19(9):919-29. doi: 10.1634/theoncologist.2014-0084. Epub 2014 Jul 25. Oncologist. 2014. PMID: 25063228 Free PMC article. Review.
-
Current opinions on nephrolithiasis associated with primary hyperparathyroidism.Urolithiasis. 2018 Oct;46(5):453-457. doi: 10.1007/s00240-018-1038-x. Epub 2018 Jan 19. Urolithiasis. 2018. PMID: 29350243 Review.
Cited by
-
Natural history and complications of normocalcemic hyperparathyroidism: a retrospective cohort study.JBMR Plus. 2024 May 31;8(7):ziae074. doi: 10.1093/jbmrpl/ziae074. eCollection 2024 Jul. JBMR Plus. 2024. PMID: 39290342 Free PMC article.
-
Older Patients With Asymptomatic Primary Hyperparathyroidism: Should Criteria for Surgery Be Expanded?J Endocr Soc. 2023 Aug 4;7(9):bvad098. doi: 10.1210/jendso/bvad098. eCollection 2023 Aug 2. J Endocr Soc. 2023. PMID: 37873505 Free PMC article.
-
Development and validation of a nomogram for risk prediction of nephrolithiasis recurrence in patients with primary hyperparathyroidism.Front Endocrinol (Lausanne). 2022 Aug 31;13:947497. doi: 10.3389/fendo.2022.947497. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36120445 Free PMC article.
-
Kidney Stone Events Following Parathyroidectomy vs Nonoperative Management for Primary Hyperparathyroidism.J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2801-e2811. doi: 10.1210/clinem/dgac193. J Clin Endocrinol Metab. 2022. PMID: 35363858 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
